SS
OCEA

SBI Securities’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

SBI Securities’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,617
Closed -$195 – 4263
2025
Q1 		$195 Buy
3,617
+3,600
+21,176% +$860 ﹤0.01% 3231
2024
Q4 		$9 Buy
+17
New +$13 ﹤0.01% 3946

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

SBI Securities's OCEA Position: Q2 2025 in Review

SBI Securities sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 3,617 shares — an estimated $195 sold.

SBI Securities first reported a position in OCEA in Q4 2024 and held it in 2 quarters. The position peaked at $195 in Q1 2025. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • SBI Securities reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • SBI Securities sold 3,617 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $195.
  • SBI Securities first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
  • SBI Securities's Ocean Biomedical, Inc. Common Stock position peaked at $195 in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.